Skip to main content
Signal8

Tucker Joseph Edward

SEC insider (Form 3/4/5 filer). CIK 0001883914. Chief Executive Officer at Enveric Biosciences, Inc. (ENVB) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in CAMBRIDGE, MA.

Companies Tucker Joseph Edward has filed insider reports for

  • Enveric Biosciences, Inc. (ENVB): Director, Officer, Chief Executive Officer
  • Lakewood-Amedex Biotherapeutics Inc. (LABT): Director
Tucker Joseph Edward profile photo

Tucker Joseph Edward

CIK: 0001883914

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Enveric Biosciences, Inc. logo
ENVB

Enveric Biosciences, Inc.

DirectorOfficer
Lakewood-Amedex Biotherapeutics Inc. logo
LABT

Lakewood-Amedex Biotherapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Enveric Biosciences, Inc. logo
    ENVB

    Enveric Biosciences, Inc.

    Jun 1, 2026
    Award
    Direct
    201.1K shares-
  • Lakewood-Amedex Biotherapeutics Inc. logo
    LABT

    Lakewood-Amedex Biotherapeutics Inc.

    Apr 24, 2026
    Award

    Warrant to acquire Common Stock

    Direct
    33.8K shares-
  • Enveric Biosciences, Inc. logo
    ENVB

    Enveric Biosciences, Inc.

    Dec 23, 2025
    Award
    Direct
    60.3K shares-
  • Enveric Biosciences, Inc. logo
    ENVB

    Enveric Biosciences, Inc.

    May 8, 2025
    Award
    Direct
    98.9K shares-
  • Enveric Biosciences, Inc. logo
    ENVB

    Enveric Biosciences, Inc.

    Oct 9, 2024
    Award
    Direct
    161.6K shares-

1-5 of 5